Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis.
Volkmann ER, Denton CP, Kolb M, Wijsenbeek-Lourens MS, Emson C, Hudson K, Amatucci AJ, Distler O, Allanore Y, Khanna D. Eur Respir Rev. 2024 Apr; 33(172). Epub 2024 Jun 12.